CKD-516

CAS No. 1188371-47-2

CKD-516( Valecobulin | CKD516 )

Catalog No. M10645 CAS No. 1188371-47-2

CKD-516 (Valecobulin, CKD516) is a potent beta-tubulin polymerization inhibitor with marked antitumor activity both in vitro and in vivo.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 267 Get Quote
50MG 1224 Get Quote
100MG 1674 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CKD-516
  • Note
    Research use only, not for human use.
  • Brief Description
    CKD-516 (Valecobulin, CKD516) is a potent beta-tubulin polymerization inhibitor with marked antitumor activity both in vitro and in vivo.
  • Description
    CKD-516 (Valecobulin, CKD516) is a potent beta-tubulin polymerization inhibitor with marked antitumor activity both in vitro and in vivo; demonstrates potent cytotoxicity against several cancer cells including P-gp overexpressing MDR positive cell line (HCT15), also induces cell cycle arrest at G(2)/M phase, which is associated with strong inhibition of tubulin polymerization; shows antitumor efficacy against both murine tumors (CT26 and 3LL) and human xenogratfs (HCT116 and HCT15) in mice.Colon Cancer Phase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    Valecobulin (5 mg/kg; intraperitoneal injection; administered on days 2, 6, 10, and 14; male BALB/C nu/nu mice) treatment shows markedly antitumor efficacy in various human tumor xenograft models. Animal Model:Male BALB/C nu/nu mice (5-6 weeks of age) with HCT-116 or HCT-15 cells Dosage:5 mg/kg Administration:Intraperitoneal injection; administered on days 2, 6, 10, and 14 Result:Had shown marked antitumor efficacy in various human tumor xenograft models.
  • Synonyms
    Valecobulin | CKD516
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Microtubule/Tubulin
  • Recptor
    Microtubule/Tubulin
  • Research Area
    Cancer
  • Indication
    Colon Cancer

Chemical Information

  • CAS Number
    1188371-47-2
  • Formula Weight
    536.607
  • Molecular Formula
    C26H28N6O5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (232.95 mM)
  • SMILES
    CC(C)[C@H](N)C(NC1=NC(C2=CC=C(C(C3=CC(OC)=C(OC)C(OC)=C3)=O)C(N4N=CN=C4)=C2)=CS1)=O
  • Chemical Name
    (2S)-2-amino-3-methyl-N-{4-[3-(1H-1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl]-1,3-thiazol-2-yl}butanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lee J, et al. J Med Chem. 2010 Sep 9;53(17):6337-54. 2. Kim KW, et al. Invest New Drugs. 2013 Oct;31(5):1097-106. 3. Lee J, et al. Bioorg Med Chem Lett. 2010 Nov 1;20(21):6327-30. 4. Kim YI, et al. Anticancer Res. 2014 Apr;34(4):1715-22.
molnova catalog
related products
  • Taccalonolide B

    Taccalonolide B is effective in vitro against cell lines that overexpress P-glycoprotein (Pgp) and multidrug-resistance protein (MRP7).?Taccalonolide B inhibits growth of SK-OV-3 cells with an IC50 of 208 nM.The structures were elucidated using a combination of spectroscopic methods, including 1D and 2D NMR and HR-ESI-MS.

  • Vinorelbine

    Vinorelbine (KW-2307) is a vinca alkaloid chemotherapy agent that inhibits cancer cell mitosis through interaction with tubulin.

  • Cabazitaxel

    A semi-synthetic taxane and microtubule inhibitor for the treatment of hormone-refractory prostate cancer.